Seres Banks Serious Cash To Drive Microbiome Therapy To Market
Nestlé Health Science Bags US Rights To SER-109 for CDI
Seres and rival Ferring are both hoping to have the first-ever FDA-approved microbiome therapeutic but the US firm has secured a strong commercial partner in Nestlé's Aimmune pharma arm to drive SER-109 over the finishing line.
